Stock listing

Brii Biosciences Limited

Selected listing: A3CTND · LS · EUR · DE

Brii Biosciences Limited (Lang & Schwarz: A3CTND), Health Technology. Latest release Aug 20, 2026: Brii Biosciences Provides Corporate Updates and Reports…

A3CTND:LSEURDEUpdated October 2, 2026

Ticker: Lang & Schwarz: A3CTND
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: Lang & Schwarz
Currency: EUR

Latest news from Brii Biosciences Limited

Brii Biosciences Provides Corporate Updates and Reports 2026 Interim Financial Results

August 20, 2026

Brii Bio Announces Topline End-of-Treatment Data from Phase 2b ENRICH and ENHANCE Studies for the Treatment of Chronic Hepatitis B

July 2, 2026

Brii Bio Presents Late-Breaking Data from Its Phase 2 ENSURE Study at EASL Congress 2026, Further Supporting the Potential Role of BRII-179 in Achieving Durable Immunological Control of HBV

May 27, 2026

Brii Bio Presents Cross-Study Analysis of Post-Treatment HBsAg Rebound at APASL 2026

April 26, 2026

Brii Biosciences Provides Corporate Updates and Reports Full Year 2025 Financial Results

March 19, 2026

All Brii Biosciences Limited news →

Events

Replays

Brii Bioscience Ltd (BRIBF) Q4 2021 Earnings Call
Wed, Mar 23, 2022 · 08:30 AM ET
Watch
Brii Bioscience Ltd (BRIBF) Q2 2021 Earnings Call
Fri, Aug 27, 2021 · 08:00 AM ET
Watch

Research Brii Biosciences Limited

Brii Biosciences Limited company profile

View the public company page for Brii Biosciences Limited on 6ix.

Brii Biosciences Limited news

Read company news and market updates connected to Brii Biosciences Limited.

Brii Biosciences Limited investor events

Find investor webinars, events, and replay context for Brii Biosciences Limited.